[Case Study] Akari Shigemi “The importance of proper antimicrobial use for MRSA infectio ...>>
[Publication Report] Incentivizing Resilience: Accelerating Efforts to Promote the Resea ...>>
[Event Report] Investing in the Future: The Role of Investors in Saving the World from A ...>>
[Research Report] Public Opinion Survery on the Threat of Antimicrobial Resistance (AMR) ...>>
[Publication Report] Taking Action for AMR Preparedness: Spurring Antibiotic Innovation ...>>
[Case Study] Takashi Ueda “Candidemia Requires Routine Ophthalmologic Evaluation!” (AMR ...>>
[Press Release] Himeji City Becomes the First Government Body to Join AMR Alliance Japan ...>>
[Event Report] The 8th NIKKEI FT Communicable Diseases Conference – The AMR Consortium o ...>>
[Lecture Report] The 8th NIKKEI FT Communicable Diseases Conference – Never to Repeat th ...>>


![[Event Report] FY2022 AMR Alliance Japan Planning Meeting (December 6, 2021)](https://hgpi.org/en/wp-content/uploads/sites/2/AMRalliance-logo-11-16.jpg)
![[Policy Recommendations] “Setting Appropriate Outcome Indices in the Next AMR Action Plan” (AMR Alliance Japan, October 18, 2021)](https://hgpi.org/en/wp-content/uploads/sites/2/amr-28-top_ENG.jpg)
![[Policy Recommendations] Requests for the FY2022 Revision of the Medical Service Fee Schedule for the Control of Antimicrobial Resistance (October 12, 2021)](https://hgpi.org/en/wp-content/uploads/sites/2/amr-27-top_ENG.jpg)
